CVS

TINA.org investigated the marketing used to promote life’sDHA™, a supplement sold by CVS Pharmacy under the name Algal-900 DHA, and found that the marketing deceptively implied the product could improve memory and prevent cognitive decline without proper substantiation in violation of a 2014 FTC Order.


Highlights

  • Filed complaint with FTC
  • Objected to proposed class-action settlement
  • Parties revised settlement to address some of TINA.org's concerns

Timeline

2018
June 4

The parties in the Aliano case file a joint stipulation to dismiss the case without prejudice.

May 21

The U.S. Magistrate Judge presiding over the Aliano case recommends denying preliminary approval of the settlement agreement reached between the parties because he concluded that the named plaintiff in the case failed to demonstrate that he would fairly and adequately protect the interests of the class.

2016
September 20

The Aliano Court grants TINA.org’s Motion for Leave to file second amicus curiae letter.

August 16

TINA.org files a second letter with the Aliano Court as amicus curiae, this time opposing the amended settlement agreement and again urging the Court to deny preliminary approval of the settlement.

June 24

The parties in the Aliano case reach an amended settlement agreement, which addresses many — but not all — of the issues raised by TINA.org regarding the injunctive relief portion of the settlement, though it continues to allow CVS to make implied treatment claims and still provides insufficient monetary relief to class members.

June 17

DSM Nutritional Products sends a letter to the FTC in response to TINA.org’s June 3rd letter.

June 7

The Aliano Court grants TINA.org’s
Motion for Leave
to file amicus curiae letter.

June 3

TINA.org notifies the FTC of ongoing violations of the 2014 Commission Order. TINA.org also files a letter with the Court in the Aliano case as amicus curiae opposing the proposed settlement and urging the Court to deny preliminary approval of the settlement.

May 2

The parties in the Aliano case reach a settlement agreement.

February

A class-action lawsuit was filed against CVS over its allegedly deceptive marketing of the supplement Algal-900 DHA as “clinically shown” to improve memory and prevent cognitive decline without having adequate substantiation to support such claims. The case name is Aliano v. CVS Pharmacy, Inc.

2014
August 21

The FTC files an administrative complaint against I-Health, Inc. and Martek Biosciences Corp. for deceptively advertising the supplement BrainStrong Adult that results in an Order that prohibits the companies from claiming any supplement can improve memory or prevent cognitive decline unless the claim is substantiated by competent and reliable scientific evidence.


Featured


The Latest

Filters


Class-Action Tracker

Gold Emblem Yogurt Pretzel Twists

Class Action

Gold Emblem Yogurt Pretzel Twists

Allegations: Falsely marketing products as covered in yogurt and healthy when the coating is actually “candy-like” and contains several unhealthy ingredients

CVS Health Acne Products

Class Action

CVS Health Acne Products

Allegations: Misleadingly representing that products were safe and tested by dermatologists when they contain, or were at risk of containing, the carcinogen benzene

CVS Health Eye Drops

Class Action

CVS Health Eye Drops

Allegations: Marketing products as sterile and safe when they have been contaminated with bacteria that may cause eye infections that can lead to partial vision loss or blindness

Donations Given at CVS

Class Action

Donations Given at CVS

Allegations: Defrauding consumers by asking them to make donations to the American Diabetes Association on checkout screens when all or part of the donated money went to CVS

CVS Dry Mouth Discs

Class Action

CVS Dry Mouth Discs

Allegations: Marketing that products promote a healthy mouth when using them contributes to various oral health issues

CVS Health Gum & Enamel Repair

Class Action

CVS Health Gum & Enamel Repair

Allegations: Falsely marketing products as if they repair gums and reverse gingivitis when the active ingredient does not provide such benefits

Several Store Brand Acetaminophen Products

Class Action

Several Store Brand Acetaminophen Products

Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children

CVS Cotton Swabs

Class Action

CVS Cotton Swabs

Allegations: Deceiving consumers about the proper use for its cotton swabs and failing to adequately disclose the risks associated with using cotton swabs to clean in the ear canal

CVS Health Infants’ Pain & Fever

Class Action

CVS Health Infants’ Pain & Fever

Allegations: Misleadingly marketing the infants’ product as specifically formulated for infants when it has the same concentration of acetaminophen as the children’s version

CVS Health Clear Zinc Sunscreens

Class Action

CVS Health Clear Zinc Sunscreens

Allegations: Misleadingly marketing that the active ingredients in sunscreens are zinc oxide minerals when there are also chemical active ingredients in the sunscreens

CVS Health Infants’ Pain & Fever Acetaminophen

Class Action

CVS Health Infants’ Pain & Fever Acetaminophen

Allegations: Misleadingly marketing that the product is specifically formulated for infants and charging more for the infants’ product when it contains the same formulation of the same active ingredient in…

CVS Brand Hand Sanitizers

Class Action

CVS Brand Hand Sanitizers

Allegations: Misleadingly marketing that hand sanitizers “Kill[] 99.99% of Germs” when there is no scientific evidence to support such claims